What is Orthofix Medical Inc.'s market cap?

Orthofix Medical Inc. (OFIX) has a market capitalization of $481.0M and trades on NASDAQ.

What is Orthofix Medical Inc.'s revenue and profitability?

Orthofix Medical Inc. generated $825.4M in trailing twelve-month revenue with a net loss of $60.0M, representing a net margin of -7.3%. Gross margin stands at 70.7%, with free cash flow of -$82.9M. These figures are based on the Q1 2026 filing.

Who are Orthofix Medical Inc.'s competitors?

Orthofix Medical Inc.'s key competitors include Globus Medical, Stryker, Alphatec Spine, and others. These companies compete in similar markets and product categories.

Who does Orthofix Medical Inc. partner with?

Orthofix Medical Inc.'s notable partners include MTF Biologics, MRIguidance.

What subsidiaries does Orthofix Medical Inc. have?

Orthofix Medical Inc.'s subsidiaries include SeaSpine Holdings Corporation, IsoTis Orthobiologics, Inc., Orthofix US LLC.

Where is Orthofix Medical Inc. headquartered?

Orthofix Medical Inc. is headquartered in United States of America and employs approximately 1,634 people. It has been publicly traded since 1992.

Orthofix Medical Inc.

OFIX

Orthofix Medical Inc. is a global medical technology company specializing in musculoskeletal pathologies and regenerative solutions.

Market cap

$481.02M+8.1%

Revenue$825.4M+2.6%

Net income-$60.0M+58.1%

Free cash flow-$82.9M+21.8%

EPS (diluted)-$1.50+59.4%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 5, 2026

Revenue$196.7MBeat by $308.0K EPS-$0.52Beat by $0.16

Read the full report

Next report

Aug 5, 2026 (In 1 week)

Revenue estimate$209.3M

EPS estimate-$0.41

Financials

Q1 2026

Income statement

See full

Revenue$196.7M+1.6%

Gross profit$139.5M+14.7%

Operating income-$14.4M+70.5%

Net income-$20.9M+60.6%

EPS (diluted)-$0.52+61.5%

Balance sheet

See full

Cash & equivalents$120.3M+108%

Total debt$237.5M+32.3%

Total equity$435.2M-5.0%

Total assets$886.6M+7.7%

Cash flow

See full

Operating cash flow-$17.6M+4.2%

CapEx$10.7M+58.3%

Free cash flow-$28.3M-12.5%

Valuation & ratios

Valuation

See full

Market cap$481.02M+8.1%

Enterprise value$598.23M+6.9%

P/S0.6×0.0×

Profitability

See full

Gross margin70.7%+3.6pp

Operating margin-5.8%-2.1pp

Net margin-7.3%-2.7pp

Returns & leverage

See full

Return on equity-13.4%-4.6pp

Debt / equity0.5×+0.2×

Current ratio2.9×+0.2×

Segments

By segment

See full

Global Spine$163.9M0.0%

Global Limb Reconstruction$32.9M—

Competitors

By market cap

Johnson & Johnson$640.91B+60.1%

Stryker$129.09B-15.7%

Medtronic$107.81B-8.5%

Globus Medical$10.6B+44.5%

Enovis$1.6B+4.2%

Alphatec Holdings$1.3B-18.5%

Bioventus$843.5M+94.7%

Orthofix Medical Inc.$481.0M+7.7%

By revenue growth

Globus Medical+23.5%

Alphatec Holdings+22.6%

Stryker+8.8%

Medtronic+8.4%

Johnson & Johnson+8.1%

Enovis+6.0%

Orthofix Medical Inc.+2.6%

Bioventus+1.5%

By net margin

Johnson & Johnson21.48%-3.5pp

Globus Medical18.92%+11.5pp

Stryker13.21%+0.9pp

Medtronic13.2%-0.7pp

Bioventus4.94%+10.9pp

Orthofix Medical Inc.-7.27%+10.5pp

Alphatec Holdings-15.93%+9.8pp

Enovis-49.91%-12.3pp

Profile

Orthofix Medical Inc. is a global medical technology company specializing in musculoskeletal pathologies and regenerative solutions. The company provides a comprehensive portfolio of spinal hardware, bone growth therapies, limb reconstruction solutions, and biologics. Its core value proposition centers on delivering life-changing surgical and non-surgical solutions through proprietary technologies like pulsed electromagnetic field (PEMF) therapy and machine-vision surgical navigation.

Competitive position

A leading provider in the bone growth stimulation market and a significant player in spinal implants and limb reconstruction, distinguished by being the only manufacturer offering both PEMF and LIPUS technologies.

GeographiesUnited States, Italy, Canada, Germany, Spain, China

Customer segmentsOrthopedic Surgeons, Neurosurgeons, Healthcare Facilities

Business modelManufacturing, Direct Sales, Distributor Network, Capital Equipment Sales

SuppliersHuman tissue banks (AATB accredited), Bovine tissue suppliers, Specialized component manufacturers, Raw material suppliers (PEEK, Titanium, Stainless Steel)

CustomersHospitals, Ambulatory Surgery Centers, Specialty Orthopedic Clinics, Patients (for home-use stimulation devices)

CountryUnited States of America

Listed1992

Employees1.6K

CEOMassimo Calafiore

SectorHealthcare

IndustryMedical - Devices

Websiteorthofix.com

FilingsSEC EDGAR

Ask your AI about Orthofix Medical Inc..

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Orthofix Medical Inc.'s market cap?: Orthofix Medical Inc. (OFIX) has a market capitalization of $481.0M and trades on NASDAQ.
What is Orthofix Medical Inc.'s revenue and profitability?: Orthofix Medical Inc. generated $825.4M in trailing twelve-month revenue with a net loss of $60.0M, representing a net margin of -7.3%. Gross margin stands at 70.7%, with free cash flow of -$82.9M. These figures are based on the Q1 2026 filing.
Who are Orthofix Medical Inc.'s competitors?: Orthofix Medical Inc.'s key competitors include Globus Medical, Stryker, Alphatec Spine, and others. These companies compete in similar markets and product categories.
Who does Orthofix Medical Inc. partner with?: Orthofix Medical Inc.'s notable partners include MTF Biologics, MRIguidance.
What subsidiaries does Orthofix Medical Inc. have?: Orthofix Medical Inc.'s subsidiaries include SeaSpine Holdings Corporation, IsoTis Orthobiologics, Inc., Orthofix US LLC.
Where is Orthofix Medical Inc. headquartered?: Orthofix Medical Inc. is headquartered in United States of America and employs approximately 1,634 people. It has been publicly traded since 1992.